Multidrug resistance phenotype by treatment arm
. | HDAC/DNR, n = 40 . | HDAC/DNR + CsA, n = 37 . | ||
---|---|---|---|---|
No. positive/no. patients . | Percentage . | No. positive/no. patients . | Percentage . | |
Duplicate Ph | 5/37 | 14 | 5/36 | 14 |
Pgp* | 20/36 | 56 | 22/36 | 61 |
CsA-inhibited DiOC2 efflux† | 22/36 | 61 | 21/36 | 58 |
MRP1* | 8/36 | 22 | 5/36 | 14 |
LRP* | 23/35 | 66 | 28/36 | 78 |
. | HDAC/DNR, n = 40 . | HDAC/DNR + CsA, n = 37 . | ||
---|---|---|---|---|
No. positive/no. patients . | Percentage . | No. positive/no. patients . | Percentage . | |
Duplicate Ph | 5/37 | 14 | 5/36 | 14 |
Pgp* | 20/36 | 56 | 22/36 | 61 |
CsA-inhibited DiOC2 efflux† | 22/36 | 61 | 21/36 | 58 |
MRP1* | 8/36 | 22 | 5/36 | 14 |
LRP* | 23/35 | 66 | 28/36 | 78 |